Back to Search
Start Over
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
- Source :
- Thrombosis Research
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
- Subjects :
- 2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
medicine.medical_treatment
Pneumonia, Viral
Letter to the Editors-in-Chief
Gastroenterology
NO
Fibrin Fibrinogen Degradation Products
Betacoronavirus
COVID-19 Testing
Internal medicine
Humans
Medicine
Interleukin 6
Pandemics
Reduction (orthopedic surgery)
Venous Thrombosis
biology
Clinical Laboratory Techniques
Platelet Count
Interleukin-6
SARS-CoV-2
business.industry
COVID-19
Hematology
Blood Coagulation Disorders
COVID-19, IL-6 antagonists, Venous thromboembolism, Interleukin-6, SARS-CoV-2, COVID-19
IL-6 antagonists
Prothrombin Time
biology.protein
Coronavirus Infections
business
Venous thromboembolism
Biomarkers
Subjects
Details
- ISSN :
- 00493848
- Volume :
- 208
- Database :
- OpenAIRE
- Journal :
- Thrombosis Research
- Accession number :
- edsair.doi.dedup.....3f34e3ad51fadf5c2aa9f827cc307e48